Protocol Number: 96-C-0102

Title:

Evaluation and Treatment of Subjects with Dermatologic Diseases

Number:

96-C-0102

Summary:

This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.

Sponsoring Institute:

National Cancer Institute (NCI)

Recruitment Detail

Type: Participants currently recruited/enrolled

Gender: Male & Female

Referral Letter Required: Yes

Population Exclusion(s): None

Eligibility Criteria:

INCLUSION CRITERIA:

Patients of any age, of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations.

Women of childbearing potential, or who are pregnant or lactating, will undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus or child. Only tests that are clinically indicated for diagnosis will be performed.

Patients must be referred by a physician.

EXCLUSION CRITERIA:

Patients with cognitive impairment.

Pregnancy or lactation, if this status precludes proposed diagnostic procedures or therapies because of known untoward effects on mother and/or child.

Special Instructions:

Federal regulations for the protection of human subjects require approval of clinical trials by your local Institutional Review Board.

Keywords:

Training Protocol

Natural History

Consultation

Standard Therapy

Standard Tests

Recruitment Keyword(s):

None

Condition(s):

Connective Tissue Disease

Skin Disease

Investigational Drug(s):

None

Investigational Device(s):

None

Intervention(s):

None

Supporting Site:

National Cancer Institute

Contact(s):

NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
Phone: 1-888-NCI-1937
Fax: Not Listed
Electronic Address: ncicssc@mail.nih.gov

Citation(s):

Keloids: a review

• Questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
• Technical questions regarding the Clinical Center web site, please contact the Department of Clinical Research Informatics, CC.

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

National Institutes of Health Clinical Center Bethesda, Maryland 20892. Last update: 01/13/2009